Lilly and TransPharma Medical Announce Licensing and Development... (th age in both women and men.(iii) Ve...)

Lilly and TransPharma Medical Announce Licensing and Development Agreement

Date:6/12/2008

th age in both women and men.(iii)

Vertebral fractures can result in serious consequences, including loss of height, intense back pain and deformity.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

About TransPharma Medical

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology. TransPharma aims to develop multiple drug products through strategic partnerships with leading pharmaceutical companies and through independent product development. For more information, visit the Company's website at http://www.transpharma-medical.com.

This news release contains forward-looking statements. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a difference include, among others, the completion of clinical trials, the FDA and other foreign review processes and other governmental regulation, Lilly's and TransPharma's abilities to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, the ability to effectively market products, and other factors described in Lilly's most recent filings with the Securities and Exchange C
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4
Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration

Post Your Comments:

(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... assessment of the competitive environment is ... management responsibilities, the task crucial to ... and factual competitive intelligence is vital ...

(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The Future ... to 2015, Competitive Benchmarking, Product Pipeline ... http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, Summary ... latest research "The Future of HIV ...

(Date:12/15/2009)... Mass., Dec. 15 NxStage Medical, Inc. ... innovative dialysis products, today announced that a group ... will be embarking on a week-long, conventional (non-dialysis) ... The cruise, dubbed the "2010 Freedom Cruise: ... Miami, Fla. on January 3, 2010 and returns ...

[0] Reportlinker Adds Top Ten World's Leading Orthopedics Companies [0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM)

... WIRE)--Jul 3, 2007 - EPIX,Pharmaceuticals, Inc. (NASDAQ:EPIX) today ... officer of EPIX, is,scheduled to present at the ... July 10, 2007 at 1:30 p.m.,(EDT) at the ... presentation will be webcast live and can be ...

... July 03, 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. ... President,Corporate Development and Finance, will present a ... Emerging Growth Conference on July 12,2007 at ... NY. , Interested parties may access the ...

Other Medicine Technology:EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference 2 Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin,Emerging Growth Conference 2

EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin,Emerging Growth Conference

(Date:12/16/2009)... Awarded American Podiatric Medical Association’s Seal of Acceptance , ... ... -- As shoppers continue their search for the perfect gift ... for items that are considered healthy for the environment. When ... many of today’s most stylish items are also healthy for ...

(Date:12/16/2009)... nationwide confidential legal consultations for users of Paxil who have ... Attempted Suicide, Suicide and Addiction Issues. Individuals suffering from Paxil ... to the firm’s website at http://www.ennislaw.com and fill ... ... (PRWEB) December 16, 2009 -- Bloomberg news reported ...

(Date:12/15/2009)... failure of the U.S. Senate to allow importation ... the more effective direct bulk purchasing of prescription ... big industry controls the health reform debate, according ... Senator Dorgan (D-ND) was a relatively modest proposal, ... Medicare to directly negotiate discounts with drug manufacturers," ...

(Date:12/15/2009)... Dec. 15 Palo Alto Networks(TM), the ... has deployed its PA-4000 Series next-generation firewalls for ... for enhanced visibility and control over applications such ... a Japanese national university with eight facilities on ... by integrating a number of academic schools and ...

(Date:12/15/2009)... area where all couples of reproductive age were evaluated, ... -- The number of children born with cystic fibrosis ... CF mutation carriers increases, a new study finds. , ... of northeast Italy for many years. Since the 1990s, ... the number of infants born with CF. , Two ...

Breaking Medicine News(10 mins):Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 2 Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 3 Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 4 Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2 Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3 Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2 Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3 Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2 Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3 Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2

[0] Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products [0] Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil [1] Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog [1] Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University [0] Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis

... The ,Help is Here Express, bus tour will be ... - May 1 at various cities in order to ... that provide prescription medicines for free or nearly free. ... the Partnership for Prescription Assistance (PPA) is ready to ...

... make an appropriate decision regarding care for patients ... according to a study performed at St. Joseph,s ... included 62 patients. Results showed that, "approximately 50% ... ultrasound evaluation," said Srinivasan Harish, lead author of ...

... University School of Medicine (BUSM) have found that some ... a brief intervention. The BUSM study appears in the ... and Drugs . , "Brief intervention shows promise for ... with higher cognitive functioning or an alcohol- attributable diagnosis," ...

... High fructose corn syrup ,misunderstood,WASHINGTON, April 23 ... Williams ran a report, "The sweet truth about ... Robert Bazell. In the report, Mr. Bazell ... little difference between the two products." ( ...

... WASHINGTON, April 23 The YWCA USA applauds President Obama,s ... their time and talent to improve their local communities. ... bill and called on Americans to learn about volunteer and ... moment in history," he said. "I,m not going to tell ...

... imaging (DWI) to determine whether or not a breast ... breast biopsies, according to a study performed at the ... a method that produces images detecting the exchange of ... study included 80 patients with 85 lesions. Quantitative analysis ...

Other Medicine News:Health News:Partnership for Prescription Assistance Prepared to Help Missouri Workers Hurt by Recession 2 Health News:Partnership for Prescription Assistance Prepared to Help Missouri Workers Hurt by Recession 3 Health News:Partnership for Prescription Assistance Prepared to Help Missouri Workers Hurt by Recession 4 Health News:Researchers find medical inpatients with unhealthy alcohol use may benefit from brief intervention 2 Health News:Landmark NBC News Nutrition Report: 'There Is Indeed Little Difference Between High Fructose Corn Syrup and Table Sugar' 2 Health News:YWCA USA Applauds President Obama's National Call for Volunteer Service 2

Partnership for Prescription Assistance Prepared to Help Missouri Workers Hurt by Recession Ultrasound changes care of some patients with rheumatic conditions Researchers find medical inpatients with unhealthy alcohol use may benefit from brief intervention Landmark NBC News Nutrition Report: 'There Is Indeed Little Difference Between High Fructose Corn Syrup and Table Sugar'YWCA USA Applauds President Obama's National Call for Volunteer Service New MR technique may help save women from unnecessary breast biopsies

... is a full-featured product capable of ... of the ophthalmic practice. This fully ... financial, administrative and clinical management needs ... as a scaleable solution, VersaVision can ...

... There is an important movement in ... access for handicapped persons. In fact, recent ... provides both. This ingenious device affords your ... your lane of equipment without having to ...

... ReSeeVit 5Z slit lamp is designed ... imaging. This video-ready slit lamp offers ... It is another addition to the ... offers the best products on the ...

... the newest and most advanced automated immunoassay ... AIA-1800 launches with a full menu of ... reproductive, cardiac, and anemia assays. ,The AIA-1800 ... primary tube sampling, auto dilution, auto pretreatment, ...

Medicine Products:

VersaSuite Access Slide Exam Chair ReSeeVit 5Z AIA-1800

Lilly and TransPharma Medical Announce Licensing and Development...(th age in both women and men.(iii) Ve...),Health